Universe Pharmaceuticals INC Selling Expense
Universe Pharmaceuticals INC (UPC) reported Selling Expense of $4.80 billion for the 12-month period ending 2025-09-30, per its 20-F filed 2026-01-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingExpense · last filed 2026-01-29
| Period end | Selling Expense 6 month | Selling Expense 12 month | Selling Expense 12 month as first filed |
|---|---|---|---|
| 2025-09-30 | $4.80B 20-F · filed 2026-01-29 | ||
| 2024-09-30 | $8.17B 20-F · filed 2026-01-29 | $8.17M 20-F · filed 2025-04-29 | |
| 2024-03-31 | $4.05M 6-K · filed 2024-09-20 | ||
| 2023-09-30 | $6.78B 20-F · filed 2026-01-29 | $6.78M 20-F · filed 2024-01-30 | |
| 2023-03-31 | $2.33M 6-K · filed 2024-09-20 | ||
| 2022-09-30 | $19.08M 20-F · filed 2025-04-29 | ||
| 2022-03-31 | $9.08M 6-K · filed 2023-08-31 | ||
| 2021-09-30 | $2.97M 20-F · filed 2024-01-30 | ||
| 2021-03-31 | $1.11M 6-K · filed 2022-08-16 | ||
| 2020-09-30 | $1.56M 20-F · filed 2023-02-10 | ||
| 2019-09-30 | $1.58M 20-F · filed 2022-01-31 |